Publications by authors named "De Murphy"

Claim this Profile
T
T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles.
Jaime Fernández Bimbo, Eline van Diest, Daniel E Murphy, Ator Ashoti, Martijn J W Evers

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A descriptive analysis of dengue in Peace Corps Volunteers, 2000-2019.
Catherine T Gulley, Daniel E Murphy, Scott A Poe, Kyle Petersen

Travel Med Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural or Synthetic RNA Delivery: A Stoichiometric Comparison of Extracellular Vesicles and Synthetic Nanoparticles.
Daniel E Murphy, Olivier G de Jong, Martijn J W Evers, Maratussholikhah Nurazizah, Raymond M Schiffelers

Nano Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA.
Olivier G de Jong, Daniel E Murphy, Imre Mäger, Eduard Willms, Antonio Garcia-Guerra

Nat Commun· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CRISPR-Cas9-based reporter system for single-cell detection of extracellular vesicle-mediated functional transfer of RNA.
Olivier G de Jong, Daniel E Murphy, Imre Mäger, Eduard Willms, Antonio Garcia-Guerra

Nat Commun· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Delivery with Extracellular Vesicles: From Imagination to Innovation.
Olivier G de Jong, Sander A A Kooijmans, Daniel E Murphy, Linglei Jiang, Martijn J W Evers

Acc Chem Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking.
Daniel E Murphy, Olivier G de Jong, Maarten Brouwer, Matthew J Wood, Grégory Lavieu

Exp Mol Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of household water quality among Peace Corps volunteers in Guatemala.
Daniel E Murphy, Scott A Poe, Jennifer L Murphy, Rennie W Ferguson, Susan J Henderson

Trop Dis Travel Med Vaccines· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.
Daniel E Murphy, Ralph J Panos

Int J Chron Obstruct Pulmon Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity and sensitivity of ⁹⁹mTc-EDDA/HYNIC-Tyr³-octreotide (⁹⁹mTc-TOC) for imaging neuroendocrine tumors.
Jesús Sepúlveda-Méndez, Consuelo Arteaga de Murphy, Martha Pedraza-López, Eduardo Murphy-Stack, Juan Carlos Rojas-Bautista

Nucl Med Commun· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of chronic obstructive pulmonary disease among veterans in the urban midwest.
Daniel E Murphy, Zeshan Chaudhry, Khalid F Almoosa, Ralph J Panos

Mil Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(99m)Tc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection.
Blanca E Ocampo-García, Flor de M Ramírez, Guillermina Ferro-Flores, Luis M De León-Rodríguez, Clara L Santos-Cuevas, Consuelo Arteaga de Murphy

Nucl Med Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity of 99mTc-UBI for detecting infection foci in patients with fever in study.
Jesús Sepúlveda-Méndez, Consuelo Arteaga de Murphy, Juan Carlos Rojas-Bautista, Martha Pedraza-López

Nucl Med Commun· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.
Eva M Molina-Trinidad, Consuelo Arteaga de Murphy, Helgi Jung-Cook, Eduardo Murphy Stack, Martha Pedraza-Lopez

J Pharm Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
David A Ellis, Julie K Blazel, Chinh V Tran, Frank Ruebsam, Douglas E Murphy

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.
Frank Ruebsam, Douglas E Murphy, Chinh V Tran, Lian-Sheng Li, Jingjing Zhao

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
Frank Ruebsam, Chinh V Tran, Lian-Sheng Li, Sun Hee Kim, Alan X Xiang, Douglas E Murphy

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
Peter S Dragovich, Julie K Blazel, David A Ellis, Qing Han, Ruhi Kamran, Douglas E Murphy

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current developments in SPECT/CT systems using 99mTc-radiopharmaceuticals].
Guillermina Ferro-Flores, Consuelo Arteaga de Murphy

Rev Invest Clin· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.
Sun Hee Kim, Martin T Tran, Frank Ruebsam, Alan X Xiang, Benjamin Ayida, Douglas E Murphy

Bioorg Med Chem Lett· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial activity in serum of the 3,5-diamino-piperidine translation inhibitors.
Yuefen Zhou, Chun Chow, Douglas E Murphy, Zhongxiang Sun, Thomas Bertolini

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
Maria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, Thomas G Nolan, Daniel A Norris, Douglas E Murphy

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.
Lian-Sheng Li, Yuefen Zhou, Douglas E Murphy, Nebojsa Stankovic, Jingjing Zhao

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
Frank Ruebsam, Stephen E Webber, Martin T Tran, Chinh V Tran, Douglas E Murphy

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.
Yuefen Zhou, Stephen E Webber, Douglas E Murphy, Lian-Sheng Li, Peter S Dragovich

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis